- Home
- TSHA vs WT Comparison
TSHA vs WT Comparison
Compare TSHA & WT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TSHA | WT |
|---|---|---|
| Founded | 2019 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | TSHA | WT |
|---|---|---|
| Price | $4.49 | $16.97 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 3 |
| Target Price | $10.56 | ★ $15.00 |
| AVG Volume (30 Days) | 2.7M | ★ 4.3M |
| Earning Date | 02-25-2026 | 01-30-2026 |
| Dividend Yield | N/A | ★ 0.72% |
| EPS Growth | N/A | ★ 105.40 |
| EPS | N/A | ★ 0.64 |
| Revenue | $6,310,000.00 | ★ $457,016,000.00 |
| Revenue This Year | N/A | $17.79 |
| Revenue Next Year | N/A | $22.45 |
| P/E Ratio | ★ N/A | $25.74 |
| Revenue Growth | N/A | ★ 12.05 |
| 52 Week Low | $1.05 | $7.47 |
| 52 Week High | $6.02 | $16.66 |
Technical Indicators
Market Signals| Indicator | TSHA | WT |
|---|---|---|
| Relative Strength Index (RSI) | 40.79 | 84.21 |
| Support Level | $4.50 | $13.24 |
| Resistance Level | $4.89 | $13.77 |
| Average True Range (ATR) | 0.31 | 0.53 |
| MACD | -0.05 | 0.25 |
| Stochastic Oscillator | 12.06 | 99.50 |
Price Performance
Historical ComparisonAbout TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About WT WisdomTree Inc.
WisdomTree Inc is a financial innovator, offering a well-diversified suite of exchange-traded products (ETPs), models and solutions. It offers a broad range of ETFs and exchange-traded products (ETPs). The firm also engages in developing next-generation digital products and structures, including digital funds and tokenized assets, as well as its blockchain-native digital wallet, WisdomTree Prime. The Company conducts business under a single operating segment as an ETP sponsor and asset manager.